PTC Therapeutics

PTC's plans crash into regulatory reality as FDA demands data on 2 candidates, delaying filing
PTC's plans crash into regulatory reality as FDA demands data on 2 candidates, delaying filing
Fierce Biotech
PTC Therapeutics
FDA
Friedreich's Ataxia
Flag link:
PTC to sell spinal muscular atrophy drug royalties for $1B
PTC to sell spinal muscular atrophy drug royalties for $1B
BioPharma Dive
PTC Therapeutics
spinal muscular atrophy
Evrysdi
Royalty Pharma
Flag link:
PTC deepens layoffs as DMD drug faces loss of authorization across Europe
PTC deepens layoffs as DMD drug faces loss of authorization across Europe
Fierce Biotech
PTC Therapeutics
DMD
layoffs
Europe
Translarna
Flag link:
After FDA setback, PTC Therapeutics' DMD drug Translarna faces possible market withdrawal in Europe
After FDA setback, PTC Therapeutics' DMD drug Translarna faces possible market withdrawal in Europe
Fierce Pharma
PTC Therapeutics
DMD
Translarna
Europe
Flag link:
Biopharma Layoff Tracker 2023: Rain Oncology, Takeda, PTC and more cut staff
Biopharma Layoff Tracker 2023: Rain Oncology, Takeda, PTC and more cut staff
BioSpace
layoffs
Rain Oncology
Takeda
PTC Therapeutics
Affimed
Urovant Sciences
Roche
Novavax
Gossamer Bio
Bristol Myers Squibb
ADC Therapeutics
Flag link:
PTC Cuts Early-Stage Pipeline but Pushes Forward on FA Drug After Phase III Flop
PTC Cuts Early-Stage Pipeline but Pushes Forward on FA Drug After Phase III Flop
BioSpace
PTC Therapeutics
Friedreich's Ataxia
clinical trials
vatiquinone
Flag link:
PTC, chasing BioMarin, posts phase 3 rare disease win but fails to silence skeptics
PTC, chasing BioMarin, posts phase 3 rare disease win but fails to silence skeptics
Fierce Biotech
PTC Therapeutics
Biomarin
PKU
clinical trials
Flag link:
Biotech heads towards big catalysts
Biotech heads towards big catalysts
EP Vantage
biotech
clinical trials
Alnylam Pharmaceuticals
Arcus Biosciences
Argenx
Arrowhead Pharmaceuticals
Axsome Therapeutics
Bavarian Nordic
FibroGen
Gilead Sciences
Incyte
Morphic Therapeutic
PTC Therapeutics
Syndax Pharmaceuticals
Travere Therapeutics
Vaxcyte
Flag link:
Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy
Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy
CP Wire
PTC Therapeutics
Novartis
Zolgensma
SMA
Novo Nordisk
Ozempic
obesity
diabetes
Baxter
M&A
Celltrio
Thermo Fisher
Pfizer
Astellas
Xtandi
NIH
Flag link:
Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy
PTC Therapeutics
Novartis
Zolgensma
SMA
Novo Nordisk
Ozempic
obesity
diabetes
Baxter
M&A
Celltrio
Thermo Fisher
Pfizer
Astellas
Xtandi
NIH
Flag link:
PTC Therapeutics CEO Stuart Peltz to retire after 25 years
PTC Therapeutics CEO Stuart Peltz to retire after 25 years
NASDAQ.com
Pharma CEOs
PTC Therapeutics
Stuart Peltz
Flag link:
Promising gene therapy delivers treatment directly to brain
Promising gene therapy delivers treatment directly to brain
Stat
gene therapy
brain
drug delivery
PTC Therapeutics
Flag link:
Huntington's Disease Continues to Baffle Biopharma
Huntington's Disease Continues to Baffle Biopharma
BioSpace
Huntington's disease
Triplet Therapeutics
PTC Therapeutics
Flag link:
Biogen, BioAge and PTC Present Novel MoAs in Neurodegenerative Diseases
Biogen, BioAge and PTC Present Novel MoAs in Neurodegenerative Diseases
BioSpace
neurodegenerative disease
Biogen
BioAge Labs
PTC Therapeutics
Flag link:
PTC Ready to Take Another Shot at FDA Approval of DMD Drug
PTC Ready to Take Another Shot at FDA Approval of DMD Drug
BioSpace
PTC Therapeutics
Translarna
FDA
Duchenne Muscular Dystrophy
Flag link:
Roche puts pressure on SMA rivals with new FDA approval
Roche puts pressure on SMA rivals with new FDA approval
Pharmaforum
Roche
PTC Therapeutics
SMA
Evrysdi
FDA
Flag link:
PTC aims again for FDA review of Duchenne drug despite latest miss
PTC aims again for FDA review of Duchenne drug despite latest miss
BioPharma Dive
PTC Therapeutics
Translarna
Duchenne Muscular Dystrophy
FDA
Flag link:
PTC Therapeutics taps experimental cancer drug for new COVID-19 trial
PTC Therapeutics taps experimental cancer drug for new COVID-19 trial
Fierce Biotech
PTC Therapeutics
clinical trials
COVID-19
PTC29
Flag link:
OptumRx: The 3 drugs that will have the biggest impact on payers, patients in 2020
OptumRx: The 3 drugs that will have the biggest impact on payers, patients in 2020
Beckers Hospital Review
OptumRx
Roche
PTC Therapeutics
risdiplam
SMA
NS Pharma
viltolarsen
Duchenne Muscular Dystrophy
Immunomedics
Trodelvy
triple negative breast cancer
Flag link:
Stepping on BioMarin's turf, PTC Therapeutics picks up PKU drug for a song
Stepping on BioMarin's turf, PTC Therapeutics picks up PKU drug for a song
Endpoints
PTC Therapeutics
Censa Pharmaceuticals
PKU
M&A
Flag link:

Pages